BioSpace News Archive

Bone Solutions Inc., an orthobiologics technology company located in Colleyville, TX, announces it has surpassed 1,000 cases implanting OsteoCrete® in various orthopedic applications.

Lipocine Inc. announced that it has entered into securities purchase agreements with certain institutional investors providing for the purchase and sale of 10,084,034 Class A Units at an offering price of $0.595 per unit, with each Class A Unit consisting of one share of its common stock and one-half of a common warrant to purchase one share of common stock at an exercise price of $0.53 per share of common stock, in a registered direct offering priced at-the-market.

Feb. 25, 2020 13:30 UTC X4 Pharmaceuticals to Present at Two Upcoming Investor Conferences in March CAMBRIDGE, Mass.--( BUSINESS WIRE )-- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced that the management team will present and conduct one-on-one meetings at Cowen and Company’s 40th Annual Health Care Conference and Oppenheimer’s 30th Annual H

Scout Bio, a biotechnology company focused on revolutionizing pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions, announced that Mark Heffernan, Scout Bio’s Chief Executive Officer, will present a company overview and update at the 40th Annual Cowen Health Care Conference at 10:00 a.m. ET on Tuesday, March 3, 2020 in Boston, MA.

TUCSON, Ariz. , Feb. 25, 2020 /PRNewswire/ -- Emagine Solutions Technology, an award-winning medical software device company located in Tucson , announced that it has received clearance from the U.S. Food & Drug Administration (“FDA”) to market its VistaScan mobile ultrasound platform. The VistaScan platform transforms a clinician’s cell phone or tablet into a port

Surglogs, Inc., the first software company to offer a full suite of automated regulatory compliance solutions for ambulatory surgery centers and hospitals, announced that healthcare industry veteran and ambulatory accreditation expert Victoria Samper has joined the Company as Director of Regulatory Compliance.

HealthState™, the novel wellness program platform by Confirm BioSciences, increased employee participation by seventy five percent [25-February-2020] SAN DIEGO , Feb. 25, 2020 /PRNewswire/ -- Mission Healthcare, a San Diego -based home health and hospice provider, and Confirm BioSciences, a leading provider of comprehensive screening tools and solutions, today announ

Feb. 25, 2020 14:00 UTC ROCKVILLE, Md.--( BUSINESS WIRE )-- GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that Chief Executive Officer Rachel King will provide a company overview at the Cowen and Company 40th Annual Health Care Conference in Boston, on Tuesday, March 03, 2020, at 12:00 p.m. ET. To access the live webcast and subsequent archived recordings for the presentation, please visit the GlycoMimetics website at www.glycomimetics.com . About GlycoMimetics

CONMED Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 6, 2020 to all shareholders of record as of March 16, 2020.

Despite demand and availability, patients lack awareness of pharma-driven services to support medication access and adherence